HANDOK Inc. (KRX:002390)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,850
+80 (0.68%)
At close: Oct 2, 2025
0.68%
Market Cap153.94B
Revenue (ttm)500.73B
Net Income (ttm)-51.48B
Shares Out12.99M
EPS (ttm)-3,739.91
PE Ration/a
Forward PEn/a
Dividend200.00 (1.69%)
Ex-Dividend DateFeb 27, 2025
Volume13,714
Average Volume20,718
Open11,820
Previous Close11,770
Day's Range11,720 - 11,910
52-Week Range10,500 - 18,170
Beta0.48
RSI54.02
Earnings DateNov 12, 2025

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides ETC and OTC drugs; and medical devices and research products, including blood pressure monitors, cholesterol monitoring systems, insulin pumps, self monitoring system of blood glucose, and blood glucose monitoring system. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS, orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet brand; foo... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.

Financial Statements

News

There is no news available yet.